UC neurosurgeon awarded grant for tumor research
Matthew Garrett, MD, PhD, who specializes in neuro-oncology, recently received a $50,000 grant from the Neurosurgery Research and Education Foundation.
The 2021-2022 B*CURED and NREF Young Clinician Investigator Award is only given to junior faculty who are pursuing careers as clinical investigators. Only those neurosurgeons who have completed fellowship within the last two years are eligible to apply.
Matthew Garrett, MD, PhD working in his UC lab. Photo/Julie Forbes/University of Cincinnati.
The award-winning project, titled, “Targeting the malignant epigenome of IDH1 mutant gliomas,” intends to investigate a treatment for Diffuse Intrinsic Pontine Glioma (DIPG). DIPG is a rare brainstem tumor that occurs primarily in children. There is currently no cure, and it is universally fatal.
"The most commonly accepted hypothesis is that the tumors are initiated when a mutation affects the way the tumor DNA is folded and arranged,” said Garrett, assistant professor of clinical neurosurgery in the University of Cincinnati College of Medicine and a UC Health Neurosurgeon at the UC Gardner Neuroscience Institute.
Garrett’s study proposes using chaetoin, an untested compound discovered from a drug screen of hundreds of different compounds, to make tumor cells more sensitive to radiation.
Garrett will test the efficacy of this compound by injecting the human tumor cells into mice. His study will both treat the mice with this new compound and will also treat the mice with the compound in combination with other promising therapies like radiation and Panobinostat.
Featured photo at top of UC Gardner Neuroscience Institute by Mark Herboth.
Related Stories
Information Security Roadshow spreads awareness
May 3, 2024
The University of Cincinnati's Office of Information Security launched a series of 18 in-person sessions from January to April 2024, drawing nearly 350 attendees from the staff of various UC colleges and units. The Information Security Roadshow series aimed to equip the audience with knowledge on prevailing cyber threats, prevention strategies, how to report incidents and resources to stay informed and secure.
Local 12: Diabetes study focuses on how long blood sugar control...
May 3, 2024
The University of Cincinnati's Robert Cohen spoke with Local 12 about the GRADE study that shows how a new medication needs to be developed to help treat people with type two diabetes.
Local media cover $13.5 million gift benefiting ALS research and...
May 2, 2024
A historic $13.5 million gift from the estate of Hugh H. Hoffman will revolutionize amyotrophic lateral sclerosis (ALS) at the ALS Multidisciplinary Clinic at the University of Cincinnati Gardner Neuroscience Institute.